drugset / Trial / NCT00643916
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this clinical trial is to describe the safety and immunogenicity of one or two doses of Menactra® (TetraMenD) administered in children less than 2 years of age. Primary Objective: To describe the immunogenicity profile of one or two doses of Menactra® (TetraMenD) when administered to subjects aged 9, 12, 15, or 18 months in comparison to the immunogenicity of one dose of Menomune® when administered to children aged 3 years to \<6 years of age.
Timeline
- Start
- 2004-12
- Primary completion
- 2006-03
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Menactra | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Menomune® | Vaccine | 0.5 ml | Subcutaneous |